Pfizer bleeds unsuspecting public, laughs all the way to the bank with over $100bn revenue in 2022
Pfizer annual revenue is expected to reach $101.3bn in 2022, thanks to its COVID-19 vaccine and Paxlovid, an ineffective antiviral.
Source: biznews.com